Harvard spinout GRO Biosciences has a platform technology for engineering therapeutic proteins that won't prompt an immune response against them. The startup's lead program is a potential competitor to an Amgen gout drug acquired in a multi-billion dollar deal.
In one of the only pieces of health policy in the GOP's 2024 platform, the former president vows not to cut Social Security or Medicare, the health program for older and disabled Americans, or change the federal retirement age.
Boehringer's adalimumab-adbm is being offered on GoodRx's platform for $550 per two-pack, a 92% discount from the Humira list price, according to the companies.
A new eBook from MedCity News highlights the variety of technologies emerging from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant. It also explores the ethical issues AI in healthcare presents.
The shifting AI landscape. Learn about the emerging technologies from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant.
No comments